Hormonal contraceptives show differing heart risks among stressed women
View as a Web Page
News Medical
 
  Hematology Hematology logo  
  The latest hematology news from News Medical  
 Long-term omeprazole use linked to mineral imbalance risksLong-term omeprazole use linked to mineral imbalance risks
 
A study conducted in Brazil by researchers at the Federal University of São Paulo (UNIFESP) and the ABC Medical School (FMABC) warns that the prolonged use of proton pump inhibitors (PPIs) can impair nutrient absorption.
 
 
 Hormonal contraceptives show differing heart risks among stressed womenHormonal contraceptives show differing heart risks among stressed women
 
Antonia Seligowski, PhD, of the Neurocardiac Effects of Stress & Trauma Laboratory within the Department of Psychiatry at Mass General Brigham, is the senior author of a paper published in JAMA Network Open, "Hormonal contraceptive use, stress disorders, and cardiovascular and thrombotic risk in women."
 
   FDA label update expands CAR T access for primary CNS lymphomaFDA label update expands CAR T access for primary CNS lymphoma
 
Dana-Farber Cancer Institute-led research helped drive an FDA label update for axicabtagene ciloleucel (Yescarta) that removes a prior exclusion for patients with primary central nervous system lymphoma, a rare and aggressive lymphoma of the brain and spinal cord.
 
   Blocking p300 restores chemotherapy sensitivity in resistant tumorsBlocking p300 restores chemotherapy sensitivity in resistant tumors
 
Overcoming tumor resistance to chemotherapy drugs has long been a challenge for oncology clinicians and researchers.
 
   Cellares to expand automated manufacturing to gene-edited stem cell therapiesCellares to expand automated manufacturing to gene-edited stem cell therapies
 
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative Medicines Accelerator (IMA) to automate manufacturing and release testing for gene-edited hematopoietic stem cell (HSC) therapies, expanding the application of Cellares' automation platforms beyond T cell therapies into a new cell modality.
 
 Single-cell atlas reveals how melanoma evades the immune system
 
Single-cell atlas reveals how melanoma evades the immune systemIntegrative analysis of immune ecotypes in skin cancers highlights metabolic reprogramming and macrophage polarization as key factors in melanoma progression.
 
 
 Parvovirus infection disrupts nucleolar structure and cellular balance
 
Research at the University of Jyväskylä (Finland) reveals that autonomous parvoviruses, such as canine parvovirus, are highly capable of affecting the internal balance of the nucleolus.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026